Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
21.48
-1.00 (-4.43%)
At close: Nov 4, 2024, 4:00 PM
20.51
-0.97 (-4.52%)
After-hours: Nov 4, 2024, 6:13 PM EST

KNSA Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Market Capitalization
1,5511,2341,0428111,203607
Upgrade
Market Cap Growth
46.08%18.45%28.46%-32.59%98.17%-56.32%
Upgrade
Enterprise Value
1,4101,046848617840351
Upgrade
Last Close Price
22.4817.5414.9811.7717.6711.06
Upgrade
PE Ratio
-87.705.76-5.11-6.77-3.69
Upgrade
PS Ratio
4.154.574.7321.04--
Upgrade
PB Ratio
3.712.812.634.383.862.69
Upgrade
P/FCF Ratio
146.1493.67182.67-6.40-8.79-3.76
Upgrade
P/OCF Ratio
144.3292.76179.37-6.42-8.81-3.83
Upgrade
EV/Sales Ratio
3.673.873.8516.02--
Upgrade
EV/EBITDA Ratio
-64.47-45.7569.62-4.00-5.42-2.09
Upgrade
EV/EBIT Ratio
-59.96-41.5086.73-3.94-5.34-2.07
Upgrade
EV/FCF Ratio
126.9479.39148.64-4.87-6.14-2.17
Upgrade
Debt / Equity Ratio
0.020.030.010.030.020.01
Upgrade
Debt / EBITDA Ratio
--0.38---
Upgrade
Debt / FCF Ratio
0.950.931.04-0.05-0.05-0.02
Upgrade
Asset Turnover
0.740.550.640.13--
Upgrade
Inventory Turnover
5.523.413.72---
Upgrade
Quick Ratio
2.593.584.484.1510.168.39
Upgrade
Current Ratio
3.244.345.164.3810.468.68
Upgrade
Return on Equity (ROE)
-2.15%3.37%63.10%-63.55%-60.06%-64.15%
Upgrade
Return on Assets (ROA)
-3.16%-3.19%1.76%-33.63%-32.57%-36.85%
Upgrade
Return on Capital (ROIC)
-3.79%-3.69%2.06%-38.39%-35.96%-41.88%
Upgrade
Earnings Yield
-0.56%1.14%17.60%-19.48%-13.42%-26.67%
Upgrade
FCF Yield
0.68%1.07%0.55%-15.63%-11.37%-26.62%
Upgrade
Buyback Yield / Dilution
-1.53%-2.13%-2.69%-10.89%-14.42%-82.92%
Upgrade
Total Shareholder Return
-1.53%-2.13%-2.69%-10.89%-14.42%-82.92%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.